Stathmin Overexpression in Breast Cancer
Author Information
Author(s): I Bieche, S Lachkar, V Becette, C Cifuentes-Diaz, A SobeJ, R Lidereau, PA Curmi
Primary Institution: Centre Rene Huguenin, INSERM U440
Hypothesis
Does stathmin overexpression play a role in breast carcinogenesis?
Conclusion
Stathmin is overexpressed in about one-third of breast cancer cases, suggesting it may define a new subtype of the disease.
Supporting Evidence
- Stathmin was overexpressed in 15 out of 50 tumors, indicating a potential new subtype of breast cancer.
- Perfect matching was observed between stathmin mRNA overexpression and protein overexpression.
- A tentative link between loss of heterozygosity in the 1p32-1pter region and stathmin overexpression was observed.
Takeaway
Some breast cancer tumors have too much stathmin, which might help us understand a new type of breast cancer.
Methodology
The study examined stathmin mRNA and protein expression in 50 human primary breast tumors and analyzed genomic DNA for abnormalities.
Limitations
No clear correlation was found between stathmin expression and several prognosis markers.
Participant Demographics
Fifty primary breast tumor samples classified grade I-III were obtained from patients.
Statistical Information
P-Value
0.082
Statistical Significance
p=0.082
Want to read the original?
Access the complete publication on the publisher's website